School of Medicine | University of Colorado

FDA mandated trial evaluating the safety of a flow diverting stent with a phosphatidylcholine layer designed to minimize the devices thrombogenicity. Roll includes the screening and enrolling of patients, training of staff, and the performance of endovascular procedures using the study device. ................
................